Notably, the B7-H4 antibody(CH17) exhibited robust in vivo anti-tumor efficacy in a human T-cell transplantation xenograft model and synergistic effects when combined with anti-PD-1 antibody (74). This evidence concerns the gene VTCN1 and neoplasm.